Current advances in 2022: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee Review
| Authors: | Metcalf, R. A.; Cohn, C. S.; Bakhtary, S.; Gniadek, T.; Gupta, G.; Harm, S.; Haspel, R. L.; Hess, A. S.; Jacobson, J.; Lokhandwala, P. M.; Murphy, C.; Poston, J. N.; Prochaska, M. T.; Raval, J. S.; Saifee, N. H.; Salazar, E.; Shan, H.; Zantek, N. D.; Pagano, M. B. |
| Review Title: | Current advances in 2022: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee |
| Abstract: | Background: The Association for the Advancement of Blood and Biotherapies Clinical Transfusion Medicine Committee (CTMC) composes a summary of new and important advances in transfusion medicine (TM) on an annual basis. Since 2018, this has been assembled into a manuscript and published in Transfusion. Study design and methods: CTMC members selected original manuscripts relevant to TM that were published electronically and/or in print during calendar year 2022. Papers were selected based on perceived importance and/or originality. References for selected papers were made available to CTMC members to provide feedback. Members were also encouraged to identify papers that may have been omitted initially. They then worked in groups of two to three to write a summary for each new publication within their broader topic. Each topic summary was then reviewed and edited by two separate committee members. The final manuscript was assembled by the first and senior authors. While this review is extensive, it is not a systematic review and some publications considered important by readers may have been excluded. Results: For calendar year 2022, summaries of key publications were assembled for the following broader topics within TM: blood component therapy; infectious diseases, blood donor testing, and collections; patient blood management; immunohematology and genomics; hemostasis; hemoglobinopathies; apheresis and cell therapy; pediatrics; and health care disparities, diversity, equity, and inclusion. Discussion: This Committee Report reviews and summarizes important publications and advances in TM published during calendar year 2022, and maybe a useful educational tool. © 2023 AABB. |
| Keywords: | hydroxyurea; review; nonhuman; infection; anemia; food and drug administration; virus rna; gene therapy; beta thalassemia; medical society; genomics; cell therapy; systemic lupus erythematosus; hyperbilirubinemia; biological therapy; racial disparity; hypertriglyceridemia; injury; virus transmission; heart surgery; pediatrics; hemostasis; health care disparity; minority group; hemoglobinopathy; apheresis; virus infectivity; blood donor; prothrombin complex; tranexamic acid; acute pancreatitis; erythrocyte concentrate; antifibrinolytic agent; human; blood component therapy; alloimmunization; sars-cov-2 convalescent plasma; acute liver failure; transfusion medicine; childhood trauma; diversity, equity and inclusion; freeze dried plasma; lyophilized plasma; variant creutzfeldt jakob disease |
| Journal Title: | Transfusion |
| Volume: | 63 |
| Issue: | 8 |
| ISSN: | 0041-1132 |
| Publisher: | Blackwell Publishing |
| Date Published: | 2023-08-01 |
| Start Page: | 1590 |
| End Page: | 1600 |
| Language: | English |
| DOI: | 10.1111/trf.17475 |
| PUBMED: | 37403547 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Source: Scopus |
